ClinicalTrialsFinder
RecruitingPhase 2NCT03875378

Transdermal Estrogen in Women With Anorexia Nervosa

Transdermal Estrogen for the Treatment of Bone Loss in Women With Anorexia Nervosa

Sponsor

Pouneh K. Fazeli, MD

Enrollment

66 participants

Start Date

Aug 28, 2020

Study Type

INTERVENTIONAL

Conditions

Anorexia Nervosa

Summary

Randomized, placebo-controlled study investigating the use of physiologic, transdermal estrogen for low bone mass in adult women with anorexia nervosa.

Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebos and a drug called Transdermal estrogen for people with anorexia nervosa. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 19 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTransdermal estrogen

Transdermal estradiol (0.045mg)/levonorgestrel (0.015mg) weekly patch

DRUGPlacebos

Placebo weekly patch

Locations(1)

University of Pittsburgh School of Medicine

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03875378

Related Trials

Eating Disorder Dynamic Intervention

NCT076006711 location

Effects of rTMS on Food Choice in Anorexia Nervosa

NCT059188351 location

Eating Disorders Genetics Initiative 2

NCT065949135 locations

Interoceptive Exposure for Adolescents With Low Weight Eating Disorders

NCT057638491 location

Relapse Prevention and Changing Habits in Anorexia Nervosa

NCT048106241 location